Our previous studies have clearly demonstrated the role of shPCBP1-mediated EMT in the progression of mammary carcinoma in vivo and was therefore selected as an appropriate experimental context for further characterization of FAM3C/LIFR/STAT3 participation in the regulation of pathological features. The gene discussed is LIFR; the disease is breast carcinoma.